Year |
Citation |
Score |
2019 |
Isomura M, Nakamura T, Kamada A, Sasaki T, Uemura T, Hoshino Y, Matsuda M, Hu Y, Hasegawa D, Inanaga K, Sato N, Yoshizawa K, Moniz GA, Wilkie GD, Fang FG, et al. Development of an Efficient Manufacturing Process for E2212 toward Rapid Clinical Introduction Organic Process Research & Development. 23: 603-613. DOI: 10.1021/Acs.Oprd.8B00444 |
0.304 |
|
2013 |
Chase CE, Fang FG, Lewis BM, Wilkie GD, Schnaderbeck MJ, Zhu X. Process development of halaven®: Synthesis of the C1-C13 fragment from d -(-)-gulono-1,4-lactone Synlett. 24: 323-326. DOI: 10.1055/S-0032-1317919 |
0.501 |
|
2013 |
Austad B, Benayoud F, Calkins T, Campagna S, Chase C, Choi HW, Christ W, Costanzo R, Cutter J, Endo A, Fang F, Hu Y, Lewis B, Lewis M, McKenna S, ... ... Wilkie G, et al. Process development of halaven®: Synthesis of the C14-C35 fragment via iterative Nozaki-Hiyama-Kishi reaction-Williamson Ether cyclization (Synlett (2013) 24 (327)) Synlett. 24: e2. DOI: 10.1055/S-0032-1317798 |
0.561 |
|
2000 |
Boger DL, Sato H, Lerner AE, Hedrick MP, Fecik RA, Miyauchi H, Wilkie GD, Austin BJ, Patricelli MP, Cravatt BF. Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide. Proceedings of the National Academy of Sciences of the United States of America. 97: 5044-9. PMID 10805767 DOI: 10.1073/Pnas.97.10.5044 |
0.494 |
|
Show low-probability matches. |